HEADER DNA/ANTIBIOTIC 15-DEC-95 1FJA TITLE NMR STUDY OF DEOXYRIBONUCLEIC ACID COMPLEXED WITH ACTINOMYCIN D COMPND MOL_ID: 1; COMPND 2 MOLECULE: DNA (5'-D(*AP*AP*GP*CP*GP*CP*TP*T)-3'); COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: ACTINOMYCIN D; COMPND 7 CHAIN: C, D; COMPND 8 SYNONYM: DACTINOMYCIN; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 MOL_ID: 2; SOURCE 4 SYNTHETIC: YES; SOURCE 5 ORGANISM_SCIENTIFIC: STREPTOMYCES ANTIBIOTICUS; SOURCE 6 ORGANISM_TAXID: 1890 KEYWDS ACTINOMYCIN D, ACTINOMYCIN, ANTI CANCER, ANTITUMOR, ANTIBIOTIC, KEYWDS 2 CHROMOPHORE, DEPSIPEPTIDE, DNA-ANTIBIOTIC COMPLEX EXPDTA SOLUTION NMR NUMMDL 5 AUTHOR H.CHEN,X.LIU,D.J.PATEL REVDAT 7 13-NOV-24 1FJA 1 REMARK REVDAT 6 10-JUL-24 1FJA 1 COMPND FORMUL LINK REVDAT 5 15-NOV-23 1FJA 1 LINK ATOM REVDAT 4 27-JUL-11 1FJA 1 ATOM REMARK REVDAT 3 13-JUL-11 1FJA 1 VERSN REVDAT 2 24-FEB-09 1FJA 1 VERSN REVDAT 1 10-JUN-96 1FJA 0 JRNL AUTH H.CHEN,X.LIU,D.J.PATEL JRNL TITL DNA BENDING AND UNWINDING ASSOCIATED WITH ACTINOMYCIN D JRNL TITL 2 ANTIBIOTICS BOUND TO PARTIALLY OVERLAPPING SITES ON DNA. JRNL REF J.MOL.BIOL. V. 258 457 1996 JRNL REFN ISSN 0022-2836 JRNL PMID 8642603 JRNL DOI 10.1006/JMBI.1996.0262 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1FJA COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000173307. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : NULL REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL REMARK 210 SPECTROMETER FIELD STRENGTH : NULL REMARK 210 SPECTROMETER MODEL : NULL REMARK 210 SPECTROMETER MANUFACTURER : NULL REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : 5 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ACTINOMYCIN D IS A BICYCLIC PEPTIDE, A MEMBER OF THE REMARK 400 ACTINOMYCIN FAMILY. REMARK 400 HERE, ACTINOMYCIN D IS REPRESENTED BY THE SEQUENCE (SEQRES) REMARK 400 REMARK 400 THE ACTINOMYCIN D IS POLYPEPTIDE, A MEMBER OF ANTIBIOTIC CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: ACTINOMYCIN D REMARK 400 CHAIN: C, D REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: ACTINOMYCIN D CONSISTS OF TWO PENTAMER RINGS LINKED REMARK 400 BY THE CHROMOPHORE (PXZ) REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-5 REMARK 465 RES C SSSEQI REMARK 465 DA A 1 REMARK 465 DT A 8 REMARK 465 DA B 1 REMARK 465 DT B 8 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (RES=RESIDUE NAME; REMARK 470 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 470 MODELS 1-5 REMARK 470 RES CSSEQI ATOMS REMARK 470 DA A 2 P OP1 OP2 REMARK 470 DA B 2 P OP1 OP2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 1 DC A 4 C4' DC A 4 C3' -0.064 REMARK 500 1 DC B 4 C4' DC B 4 C3' -0.066 REMARK 500 2 DC B 4 C4' DC B 4 C3' -0.060 REMARK 500 3 DC A 4 C4' DC A 4 C3' -0.066 REMARK 500 3 DC B 4 C4' DC B 4 C3' -0.067 REMARK 500 4 DC A 4 C4' DC A 4 C3' -0.067 REMARK 500 4 DC B 4 C4' DC B 4 C3' -0.064 REMARK 500 5 DC A 4 C4' DC A 4 C3' -0.063 REMARK 500 5 DC B 4 C4' DC B 4 C3' -0.063 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 1 DA A 2 N7 - C8 - N9 ANGL. DEV. = 3.5 DEGREES REMARK 500 1 DA A 2 C8 - N9 - C4 ANGL. DEV. = -2.9 DEGREES REMARK 500 1 DG A 3 O4' - C1' - N9 ANGL. DEV. = 3.9 DEGREES REMARK 500 1 DG A 3 N7 - C8 - N9 ANGL. DEV. = 4.4 DEGREES REMARK 500 1 DG A 3 C8 - N9 - C4 ANGL. DEV. = -2.9 DEGREES REMARK 500 1 DC A 4 O4' - C4' - C3' ANGL. DEV. = 4.7 DEGREES REMARK 500 1 DC A 4 O4' - C1' - N1 ANGL. DEV. = 2.2 DEGREES REMARK 500 1 DG A 5 N7 - C8 - N9 ANGL. DEV. = 4.0 DEGREES REMARK 500 1 DG A 5 C8 - N9 - C4 ANGL. DEV. = -2.6 DEGREES REMARK 500 1 DC A 6 O4' - C1' - N1 ANGL. DEV. = 2.1 DEGREES REMARK 500 1 DT A 7 O4' - C1' - N1 ANGL. DEV. = 3.0 DEGREES REMARK 500 1 DA B 2 N7 - C8 - N9 ANGL. DEV. = 3.4 DEGREES REMARK 500 1 DA B 2 C8 - N9 - C4 ANGL. DEV. = -2.9 DEGREES REMARK 500 1 DG B 3 O4' - C1' - N9 ANGL. DEV. = 3.9 DEGREES REMARK 500 1 DG B 3 N7 - C8 - N9 ANGL. DEV. = 4.3 DEGREES REMARK 500 1 DG B 3 C8 - N9 - C4 ANGL. DEV. = -2.9 DEGREES REMARK 500 1 DC B 4 O4' - C4' - C3' ANGL. DEV. = 4.7 DEGREES REMARK 500 1 DC B 4 O4' - C1' - N1 ANGL. DEV. = 2.2 DEGREES REMARK 500 1 DG B 5 N7 - C8 - N9 ANGL. DEV. = 4.1 DEGREES REMARK 500 1 DG B 5 C8 - N9 - C4 ANGL. DEV. = -2.6 DEGREES REMARK 500 1 DC B 6 O4' - C1' - N1 ANGL. DEV. = 1.9 DEGREES REMARK 500 1 DT B 7 O4' - C1' - N1 ANGL. DEV. = 3.1 DEGREES REMARK 500 2 DA A 2 O4' - C1' - N9 ANGL. DEV. = 3.1 DEGREES REMARK 500 2 DA A 2 N7 - C8 - N9 ANGL. DEV. = 3.5 DEGREES REMARK 500 2 DG A 3 O4' - C1' - N9 ANGL. DEV. = 4.8 DEGREES REMARK 500 2 DG A 3 N7 - C8 - N9 ANGL. DEV. = 4.2 DEGREES REMARK 500 2 DG A 3 C8 - N9 - C4 ANGL. DEV. = -2.6 DEGREES REMARK 500 2 DC A 4 O4' - C4' - C3' ANGL. DEV. = 4.8 DEGREES REMARK 500 2 DG A 5 N7 - C8 - N9 ANGL. DEV. = 4.1 DEGREES REMARK 500 2 DG A 5 C8 - N9 - C4 ANGL. DEV. = -2.7 DEGREES REMARK 500 2 DT A 7 O4' - C1' - N1 ANGL. DEV. = 2.7 DEGREES REMARK 500 2 DA B 2 O4' - C1' - N9 ANGL. DEV. = 3.3 DEGREES REMARK 500 2 DA B 2 N7 - C8 - N9 ANGL. DEV. = 3.6 DEGREES REMARK 500 2 DG B 3 O4' - C1' - N9 ANGL. DEV. = 4.8 DEGREES REMARK 500 2 DG B 3 N7 - C8 - N9 ANGL. DEV. = 4.2 DEGREES REMARK 500 2 DG B 3 C8 - N9 - C4 ANGL. DEV. = -2.5 DEGREES REMARK 500 2 DC B 4 O4' - C4' - C3' ANGL. DEV. = 4.7 DEGREES REMARK 500 2 DG B 5 N7 - C8 - N9 ANGL. DEV. = 4.1 DEGREES REMARK 500 2 DG B 5 C8 - N9 - C4 ANGL. DEV. = -2.7 DEGREES REMARK 500 2 DT B 7 O4' - C1' - N1 ANGL. DEV. = 2.6 DEGREES REMARK 500 3 DA A 2 O4' - C1' - N9 ANGL. DEV. = 2.8 DEGREES REMARK 500 3 DA A 2 N7 - C8 - N9 ANGL. DEV. = 3.6 DEGREES REMARK 500 3 DG A 3 O4' - C1' - N9 ANGL. DEV. = 5.6 DEGREES REMARK 500 3 DG A 3 N7 - C8 - N9 ANGL. DEV. = 4.5 DEGREES REMARK 500 3 DG A 3 C8 - N9 - C4 ANGL. DEV. = -3.2 DEGREES REMARK 500 3 DC A 4 O4' - C4' - C3' ANGL. DEV. = 4.9 DEGREES REMARK 500 3 DC A 4 O4' - C1' - N1 ANGL. DEV. = 1.9 DEGREES REMARK 500 3 DG A 5 N7 - C8 - N9 ANGL. DEV. = 4.2 DEGREES REMARK 500 3 DG A 5 C8 - N9 - C4 ANGL. DEV. = -2.7 DEGREES REMARK 500 3 DC A 6 O4' - C1' - N1 ANGL. DEV. = 1.8 DEGREES REMARK 500 REMARK 500 THIS ENTRY HAS 104 ANGLE DEVIATIONS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF ACTINOMYCIN D REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF ACTINOMYCIN D REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A7Z RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN Z3 REMARK 900 RELATED ID: 209D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF N8-ACTINOMYCIN D COMPLEXED WITH D(GAAGCTTC)2 REMARK 900 RELATED ID: 1UNM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 7-AMINOACTINOMYCIN D COMPLEXED WITH NON- REMARK 900 COMPLEMENTARY DNA REMARK 900 RELATED ID: 1I3W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (CGATCGATCG)2 REMARK 900 RELATED ID: 1A7Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN D REMARK 900 RELATED ID: 173D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (GAAGCTTC)2 REMARK 900 RELATED ID: 2D55 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (GAAGCTTC)2 REMARK 900 RELATED ID: 1DSC RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (GAAGCTTC)2 REMARK 900 RELATED ID: 1L1V RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF ACTNIOMYCIN D COMPLEXED WITH MISMATCHED DNA REMARK 900 (GTCACCGAC) REMARK 900 RELATED ID: 316D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF F8-ACTINOMYCIN D COMPLEXED WITH DNA (GAAGCTTC)2 REMARK 900 RELATED ID: 1DSD RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (GATGCTTC)2 REMARK 900 RELATED ID: 1MNV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (ATGCTGCAT)2 REMARK 900 RELATED ID: 1UNJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 7-AMINO-ACTINOMYCIN D COMPLEXED WITH A NON- REMARK 900 COMPLEMENTARY DNA (TTAGT)2 REMARK 900 RELATED ID: 1OVF RELATED DB: PDB REMARK 900 SOLUTIOM STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (CCGTTTTGTGG) REMARK 900 2 REMARK 900 RELATED ID: 1QFI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN X2 DBREF 1FJA A 1 8 PDB 1FJA 1FJA 1 8 DBREF 1FJA B 1 8 PDB 1FJA 1FJA 1 8 DBREF 1FJA C 1 11 NOR NOR00228 NOR00228 1 11 DBREF 1FJA D 1 11 NOR NOR00228 NOR00228 1 11 SEQRES 1 A 8 DA DA DG DC DG DC DT DT SEQRES 1 B 8 DA DA DG DC DG DC DT DT SEQRES 1 C 11 THR DVA PRO SAR MVA PXZ THR DVA PRO SAR MVA SEQRES 1 D 11 THR DVA PRO SAR MVA PXZ THR DVA PRO SAR MVA HET DVA C 2 16 HET SAR C 4 10 HET MVA C 5 19 HET PXZ C 6 32 HET DVA C 8 16 HET SAR C 10 10 HET MVA C 11 19 HET DVA D 2 16 HET SAR D 4 10 HET MVA D 5 19 HET PXZ D 6 32 HET DVA D 8 16 HET SAR D 10 10 HET MVA D 11 19 HETNAM DVA D-VALINE HETNAM SAR SARCOSINE HETNAM MVA N-METHYLVALINE HETNAM PXZ 2-AMINO-1,9-DICARBONYL-4,6-DIMETHYL-10-DEHYDRO- HETNAM 2 PXZ PHENOXAZIN-3-ONE HETSYN PXZ PHENOXAZINE FORMUL 3 DVA 4(C5 H11 N O2) FORMUL 3 SAR 4(C3 H7 N O2) FORMUL 3 MVA 4(C6 H13 N O2) FORMUL 3 PXZ 2(C16 H12 N2 O6) LINK C THR C 1 N DVA C 2 1555 1555 1.31 LINK OG1 THR C 1 C MVA C 5 1555 1555 1.39 LINK N THR C 1 C0 PXZ C 6 1555 1555 1.31 LINK C DVA C 2 N PRO C 3 1555 1555 1.33 LINK C PRO C 3 N SAR C 4 1555 1555 1.33 LINK C SAR C 4 N MVA C 5 1555 1555 1.34 LINK C0' PXZ C 6 N THR C 7 1555 1555 1.31 LINK C THR C 7 N DVA C 8 1555 1555 1.31 LINK OG1 THR C 7 C MVA C 11 1555 1555 1.39 LINK C DVA C 8 N PRO C 9 1555 1555 1.32 LINK C PRO C 9 N SAR C 10 1555 1555 1.33 LINK C SAR C 10 N MVA C 11 1555 1555 1.33 LINK C THR D 1 N DVA D 2 1555 1555 1.31 LINK OG1 THR D 1 C MVA D 5 1555 1555 1.39 LINK N THR D 1 C0 PXZ D 6 1555 1555 1.31 LINK C DVA D 2 N PRO D 3 1555 1555 1.33 LINK C PRO D 3 N SAR D 4 1555 1555 1.33 LINK C SAR D 4 N MVA D 5 1555 1555 1.34 LINK C0' PXZ D 6 N THR D 7 1555 1555 1.31 LINK C THR D 7 N DVA D 8 1555 1555 1.31 LINK OG1 THR D 7 C MVA D 11 1555 1555 1.39 LINK C DVA D 8 N PRO D 9 1555 1555 1.32 LINK C PRO D 9 N SAR D 10 1555 1555 1.33 LINK C SAR D 10 N MVA D 11 1555 1555 1.33 CISPEP 1 DVA C 2 PRO C 3 1 1.29 CISPEP 2 PRO C 3 SAR C 4 1 0.04 CISPEP 3 DVA C 8 PRO C 9 1 1.38 CISPEP 4 PRO C 9 SAR C 10 1 0.42 CISPEP 5 DVA D 2 PRO D 3 1 1.24 CISPEP 6 PRO D 3 SAR D 4 1 0.04 CISPEP 7 DVA D 8 PRO D 9 1 1.43 CISPEP 8 PRO D 9 SAR D 10 1 0.17 CISPEP 9 DVA C 2 PRO C 3 2 1.39 CISPEP 10 PRO C 3 SAR C 4 2 -0.28 CISPEP 11 DVA C 8 PRO C 9 2 1.30 CISPEP 12 PRO C 9 SAR C 10 2 0.11 CISPEP 13 DVA D 2 PRO D 3 2 1.33 CISPEP 14 PRO D 3 SAR D 4 2 -0.20 CISPEP 15 DVA D 8 PRO D 9 2 1.22 CISPEP 16 PRO D 9 SAR D 10 2 0.10 CISPEP 17 DVA C 2 PRO C 3 3 0.69 CISPEP 18 PRO C 3 SAR C 4 3 -0.07 CISPEP 19 DVA C 8 PRO C 9 3 1.65 CISPEP 20 PRO C 9 SAR C 10 3 0.11 CISPEP 21 DVA D 2 PRO D 3 3 1.06 CISPEP 22 PRO D 3 SAR D 4 3 -0.01 CISPEP 23 DVA D 8 PRO D 9 3 1.46 CISPEP 24 PRO D 9 SAR D 10 3 0.22 CISPEP 25 DVA C 2 PRO C 3 4 0.85 CISPEP 26 PRO C 3 SAR C 4 4 0.02 CISPEP 27 DVA C 8 PRO C 9 4 0.75 CISPEP 28 PRO C 9 SAR C 10 4 0.29 CISPEP 29 DVA D 2 PRO D 3 4 0.53 CISPEP 30 PRO D 3 SAR D 4 4 -0.01 CISPEP 31 DVA D 8 PRO D 9 4 0.78 CISPEP 32 PRO D 9 SAR D 10 4 0.32 CISPEP 33 DVA C 2 PRO C 3 5 0.81 CISPEP 34 PRO C 3 SAR C 4 5 0.03 CISPEP 35 DVA C 8 PRO C 9 5 0.75 CISPEP 36 PRO C 9 SAR C 10 5 0.57 CISPEP 37 DVA D 2 PRO D 3 5 0.81 CISPEP 38 PRO D 3 SAR D 4 5 0.11 CISPEP 39 DVA D 8 PRO D 9 5 0.83 CISPEP 40 PRO D 9 SAR D 10 5 0.48 SITE 1 AC1 9 DA A 2 DG A 3 DC A 4 DG B 5 SITE 2 AC1 9 DC B 6 DT B 7 PRO D 9 SAR D 10 SITE 3 AC1 9 MVA D 11 SITE 1 AC2 9 DG A 5 DC A 6 DT A 7 DA B 2 SITE 2 AC2 9 DG B 3 DC B 4 PRO C 9 SAR C 10 SITE 3 AC2 9 MVA C 11 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1